Events and webinars

The MedTech Conference

RAPS Convergence

MDR & IVDR Lessons for Regulatory Strategy

eSTAR submissions overview and live Q&A with FDA

From planning to acceptance - navigating submissions strategy and FDA market pathways for medical devices

Regulatory AMA: EU MDR Transition Period Extension

Optimizing Regulatory Communication

Quality & Regulatory Alignment for Audit Readiness

Regulatory strategy as a competitive advantage

Exploring the gap between FDA and MDR risk management requirements

RAPS Ask an Expert: Everything you wanted to know about UDI

Insights and actions from the 2023 medtech regulatory performance report

The Impact of MDR transition period extensions

Medtech Post-market essentials

Regulatory clearance for medical devices

Regulatory Ask Us Anything: Medical Device submission strategy in China for imported devices

Actionable regulatory insights and process optimization for MDR/IVDR compliance

Why a regulatory information strategy is critical for successful MDR/IVDR transitions

Regulatory AMA - What do you want to know about UDI?

Introducing Rimsys 5

Why UDI is a regulatory concern - and not just an operational process

RIM for medical devices - challenges and opportunities for automation

A medtech imperative: better regulatory information management

Integrate your regulatory stack for outsized results

Modernizing medtech product registrations

Global digital transformation for medtech regulatory affairs